Therapeutic Implications of Menin Inhibitors in the Treatment of Acute Leukemia: A Critical Review

Therapeutic Implications of Menin Inhibitors in the Treatment of Acute Leukemia: A Critical Review

Menin inhibitors are a class of targeted agents that exemplify how a deeper understanding of leukemia pathogenesis can unify seemingly distinct genetic acute leukemia subgroups under a common therapeutic strategy. In particular, acute leukemia with <i>NPM1</i> mutations <i>(NPM1<...

Full description

Saved in:

Bibliographic Details
Main Authors:	Martina Canichella, Cristina Papayannidis, Carla Mazzone, Paolo de Fabritiis
Format:	Article
Language:	English
Published:	MDPI AG 2025-07-01
Series:	Diseases
Subjects:	acute myeloid leukemia (AML) acute lymphoblastic leukemia <i>KMT2A</i> rearrangement (<i>KMT2A</i>r) <i>NPM1</i> mutation (<i>NPM1</i>m) revumenib ziftomenib
Online Access:	https://www.mdpi.com/2079-9721/13/7/227
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Targeting menin for precision therapy in high-risk acute myeloid leukemia
by: Abdur Jamil, et al.
Published: (2025-01-01)

Acute Myeloid Leukemia with Normal Cytogenetics and <i>NPM1</i>-Mutation: Impact of Mutation Topography on Outcomes
by: Mingyue Zhao, et al.
Published: (2024-12-01)

Genetic landscape of acute myeloid leukemias with leukocytosis
by: K. A. Pekhova, et al.
Published: (2023-09-01)

KMT2A degradation is observed in decitabine‐responsive acute lymphoblastic leukemia cells
by: Luisa Brock, et al.
Published: (2025-05-01)

Analysis of incidence and prognostic significance <i>FLT3, c-KIT</i> and <i>NPM1</i> genes mutation in children with acute myeloid leukemia
by: L. V. Guk, et al.
Published: (2022-11-01)

Lineage switch in relapse of acute leukemia with rearrangement of MLL gene (KMT2A). literature review and case reports
by: E. A. Zerkalenkova, et al.
Published: (2016-08-01)

Mutations in the “hot spots” of the <i>FLT3</i>, <i>NPM1</i>, <i>IDH1</i>, <i>IDH2</i> and <i>DNMT3A</i> genes in acute myeloid leukemia
by: E. N. Voropaeva, et al.
Published: (2025-03-01)

Lactylation modulation identifies key biomarkers and therapeutic targets in KMT2A-rearranged AML
by: Dan Liu, et al.
Published: (2025-01-01)

NG2 MOLECULE EXPRESSION IN ACUTE LYMPHOBLASTIC LEUKEMIA B CELLS: A FLOW-CYTOMETRIC MARKER FOR THE RAPID IDENTIFICATION OF KMT2A GENE REARRANGEMENTS
by: Maria Laura Bisegna, et al.
Published: (2024-02-01)

Insights into KMT2A rearrangements in acute myeloid leukemia: from molecular characteristics to targeted therapies
by: Sara Zehtabcheh, et al.
Published: (2025-05-01)

Loss of SMAD1 in acute myeloid leukemia with KMT2A::AFF1 and KMT2A::MLLT3 fusion genes
by: Lisa Dietsche, et al.
Published: (2025-01-01)

Prognostic Value and Correlation Between WT1 Overexpression and NPM1 Mutation in Patients with Acute Myeloblastic Leukemia
by: LL Girshova, et al.
Published: (2017-10-01)

Feasible and Rapid Screening of <i>IDH1/2</i> and <i>FLT3-TKD2</i> Mutations by High-Resolution Melting for Patients with Acute Myeloid Leukemia
by: José Vicente Gil, et al.
Published: (2025-05-01)

Association of a mutation in the <i>RUNX1</i> gene with the outcome of the disease in acute myeloid leukemia (meta-analysis)
by: M. L. Nikonorova, et al.
Published: (2023-12-01)

KMT2A-rearranged acute lymphoblastic leukaemia
by: Rishi S. Kotecha, et al.
Published: (2024-12-01)

A rare case of pediatric T-cell acute lymphoblastic leukemia with myeloid mimicry
by: Wenpeng Ni, et al.
Published: (2024-11-01)

Florid plasmacytosis in a case of acute myeloid leukemia: A diagnostic dilemma
by: Rangan Aruna, et al.
Published: (2010-03-01)

Acute Lymphoblastic Leukemia with t(4;11)(q21;q23)/KMT2A-AFF1 Translocation: The Results of Allogeneic Hematopoietic Stem Cells Transplantation in Children and Adults
by: TL Gindina, et al.
Published: (2017-07-01)

A bioinformatics analysis and experimental validation of PDGFD as a promising diagnostic biomarker for acute myeloid leukemia
by: Lulu Yang, et al.
Published: (2025-04-01)

Prognostic Value of Genetic Mutations in Patients with Acute Myeloid Leukemias: Results of a Cooperative Study of Hematology Clinics of Saint Petersburg (Russia) and Charite Clinic (Germany)
by: EV Motyko, et al.
Published: (2019-03-01)

Revumenib as A New Therapeutic Intervention for Relapsed or Refractory KMT2A-Rearranged Acute Lymphoblastic Leukemia
by: Khushbakht Baloch, et al.
Published: (2025-04-01)

Polymorphisms of the <i>TPMT</i>, <i>NUDT15</i> genes and 6-mercaptopurine toxicity profile in adult patients with Ph-negative acute lymphoblastic leukemia/lymphomas on the ALL-2016 protocol
by: E. S. Kotova, et al.
Published: (2022-07-01)

MUTATION ANALYSIS FOR NUCLEOPHOSMIN-1 (NPM1) GENE VARIANT OF CHRONIC MYELOID LEUKEMIA PATIENTS FROM LAHORE-PAKISTAN
by: Sumaira Mehboob, et al.
Published: (2025-03-01)

Targeted therapy of newly diagnosed <i>FLT3</i>-mutated acute myeloid leukemia. A single-center ambispective cohort study
by: N. K. Pastukhov, et al.
Published: (2025-03-01)

Effect of <i>ABCB1</i> Expression on Measurable Residual Disease in Adult Patients with Acute Lymphoblastic Leukemia
by: Christian Omar Ramos Peñafiel, et al.
Published: (2025-02-01)

Secondary acute myeloid leukemia after successful treatment for osteosarcoma
by: Mittal Rakesh, et al.
Published: (2010-03-01)

CD200 in acute myeloid leukemia: marked upregulation in CEBPA biallelic mutated cases
by: Laura González-Guerrero, et al.
Published: (2025-04-01)

FLT3 and NPM1 mRNA expression-based risk stratification of de novo acute Myeloid Leukemia
by: Donghyun Kim, et al.
Published: (2025-01-01)

Chromosomal Anomalies in Acute Myeloid Leukemia: Cytogenetic Results of -417 Cases Froma Single Center
by: Nüket Yürür-Kutlay, et al.
Published: (2017-04-01)

Significance of immunophenotypic, cytogenetic, and molecular markers in adult patients with T-cell lymphoblastic leukemia
by: A. N. Vasileva, et al.
Published: (2024-04-01)

The Novel Imiqualine EAPB02303 Is a Potent Drug for Treating Acute Myeloid Leukemia
by: Perla Makhoul, et al.
Published: (2025-05-01)

A long-term survivor of congenital KMT2A-R B-lymphoblastic leukemia with persistently positive bone marrow MRD and multiple CNS relapses
by: Taxiarhia J Arabatzis, et al.
Published: (2025-02-01)

Diagnostic and Therapeutic Challenge Caused by <i>Candida albicans</i> and <i>Aspergillus</i> spp. Infections in a Pediatric Patient as a Complication of Acute Lymphoblastic Leukemia Treatment: A Case Report and Literature Review
by: Natalia Zaj, et al.
Published: (2024-09-01)

Protective effects for HLA-B*40:01 and C*03:04 in NPM1-mutated AML: result of a large HLA association study
by: Elke Rücker-Braun, et al.
Published: (2025-06-01)

Tubeimoside I induces mitophagy by activating the PINK1/Parkin/Mfn2 signaling pathway in acute myeloid leukemia cells
by: Jing Xu, et al.
Published: (2025-05-01)

<i>Staphylococcus epidermidis</i> in Acute Myeloid Leukemia: A Comparative Genomic Study Against Non-AML Isolates
by: Stephanie McMahon, et al.
Published: (2025-06-01)

Intensified conditioning containing decitabine versus standard myeloablative conditioning for adult patients with KMT2A-rearranged leukemia: a multicenter retrospective study
by: Zhongli Hu, et al.
Published: (2024-12-01)

A Rare t(3;15;17) in a Patient with Acute Promyelocytic Leukemia: Case Report and Review of the Literature
by: Linda Shi, et al.
Published: (2025-07-01)

Acute promyelocytic leukemia relapsing into acute myeloid leukemia-M2 with normal cytogenetics
by: Ranjit Kumar Sahoo, et al.
Published: (2013-01-01)

Molecular Prevalence and Phylogenetic Analysis of <i>Anaplasma</i> spp. in Goats from Adana, Türkiye
by: Tülin Güven Gökmen, et al.
Published: (2025-05-01)